ArticleInternational journal of general medicine2021

Clinical Activity and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Previously Treated Small Cell Lung Cancer.

Yan-Yan Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.